@DrAngelaLamarca's caution on statistical power is the right lens for these subgroups. The pearl for fellows: daraxonrasib is a RAS(ON) multi-selective inhibitor, which is why it c

MeDucation· @MeDucationai · X·2026-10-24 00:31· 2 天前评分45

正文 · 原文

@DrAngelaLamarca's caution on statistical power is the right lens for these subgroups. The pearl for fellows: daraxonrasib is a RAS(ON) multi-selective inhibitor, which is why it can be tested across G12D, G12V and G12R, unlike G12C-only drugs. #ESMO26 #PancreaticCancer

38 浏览 · 0 赞 · 0 转发 · 0 回复

会议摘要

LBA82按 Proffered paper 1: Gastrointestinal tumour, upper digestive 对上

Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Additional subgroup analyses from the ph3 RASolute 302 study

https://esmocongress.esmo.org

来源：MeDucation · x.com